With many South Africans buckling under the current financial strain, Shoprite is the first retailer to take a decision to relieve the pressure associated with access to basic menstrual hygiene products by lowering the price of its Ultrex sanitary pad range…

Why? Because basic menstrual hygiene is a right, not a luxury.

It’s not just the monetary costs that take its toll – it’s also the physical and emotional cost. Without proper access to feminine hygiene products, seven million school-going girls between the ages of nine and 20 could miss as many as 60 days of school per year. This is a shocking statistic that adds up to two full years during their school career, leaving the women of South Africa at a distinct disadvantage to their male peers.

Many girls resort to potentially harmful alternatives such as leaves, rags or paper, which could lead to illness or infection. A lack of education and severe health risks – all for the want of a sanitary pad.

That’s why Shoprite has decided to remove the VAT on Ultrex sanitary pads. This is not a short-term promotion, but a commitment by Shoprite to provide its customers with greater access to affordable basic hygiene products and necessities.

Shoprite is covering the VAT on Ultrex pads so that you don’t have to!

Going forward, all products in the Ultrex range will retail for R10,99, with zero tax applied. This applies to both the Ultra Plus (10 pads) and Ultra Slim (12 pads) packs.

By absorbing the VAT of our sanitary products, our consumers don’t have to, thereby giving the women of South Africa greater access to affordable hygiene products, and hope for a brighter future. Because no girl should ever have to miss a day of school. Period.

For more on our #TaxFreePad movement, click here to visit the Shoprite website.

While All4Women endeavours to ensure health articles are based on scientific research, health articles should not be considered as a replacement for professional medical advice. Should you have concerns related to this content, it is advised that you discuss them with your personal healthcare provider.